On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles

Apple Inc. (AAPL.US) launches "Creator Studio" subscription package: bundling creative apps such as Final Cut Pro for a monthly fee of $12.99.

LAEKNA-B (02105): The US Food and Drug Administration has accepted the clinical trial application for the new drug LAE118.

Shanghai Longcheer Technology's H-share issue price is not more than HK$31 per share.
Apple Inc. (AAPL.US) launches "Creator Studio" subscription package: bundling creative apps such as Final Cut Pro for a monthly fee of $12.99.

LAEKNA-B (02105): The US Food and Drug Administration has accepted the clinical trial application for the new drug LAE118.

Shanghai Longcheer Technology's H-share issue price is not more than HK$31 per share.

RECOMMEND

Institutions Bullish On Hong Kong Stocks As Spring Rally Builds; Domestic And Foreign Capital Increase ETF Allocations
13/01/2026

The Sword Over Hong Kong Stocks: IPO Peaks And Unlocking Waves
13/01/2026

Learning From History: The AI Investment Wave Likely To End This Year, But The Fed May Shield U.S. Stocks
13/01/2026


